Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

New Sheba Study Indicates COVID-19 Infection Can Lower Embryo Quality

COVID-19 Infection Can Lower Embryo Quality
The study marks the first attempt to examine the impact of COVID-19 infection on IVF

22 couples participated in a first-of-its-kind study on the impact of a recent COVID-19 infection in one of the two partners in relation to the quality of embryos during an in-vitro fertilization process.

Out of the 22 couples that participated in the study, 9 required a second IVF attempt 8 to 92 days after receiving a negative COVID-19 test. The study results indicated that exposure to COVID-19 did not affect the ovarian reserve among female participants, and although the sperm quality of male participants was somewhat lower, it was not clinically significant. However, the study did indicate that the quality of the embryos produced during the IVF procedure of the aforementioned 9 couples was lower.

COVID-19 Infection Can Lower Embryo Quality

According to Prof. Raoul Orvieto, Director of the Fertility and IVF Unit: “The production of eggs and sperm lasts for around three months and can be hampered by inflammatory responses, like the ones that occur as a result of a viral infection, which is the case with COVID-19.” Prof. Orvieto added: “Our study indicated that the quality of embryos producers during an IVF procedure for a couple in which one of the partners had previously contracted COVID-19 was significantly lower, and lead to a lower chance of successful implantation.”

Concluding the study, Prof. Orvieto remarked that based on its results, couples should wait for at least three months after one of the partners has been infected with COVID-19 before starting IVF treatments. This step is meant to ensure that the eggs and sperm used during the procedure were not harmed as a result of the inflammatory response created by the virus.

virtual care
Nuvo Group and Sheba Develop AI-Powered Gestational Diabetes Management Platform
A groundbreaking gestational diabetes pilot was recently completed by the two organizations, deploying Nuvo's INVU platform at Sheba’s Beyond Virtual Hospital, simplifying care for pregnant…
Read More
pain treatment for pancreatic cancer
Breakthrough Study: Radiation Therapy Effective for Pain Management in Cancer Patients
Pancreatic cancer, the 12th most common cancer worldwide, is associated with pain in approximately 75% of patients at the time of diagnosis, and as much…
Read More
arc center
News Nov 30.
Real-Time Detection of Cancerous Biomarkers With Artificial Intelligence
Lung cancer is the most common cancer and accounts for 1.76 million deaths per year worldwide. Non-small cell lung cancer (NSCLC) comprises 85% of all…
Read More